HeartSciences - 3 Year Stock Price History | HSCS
Historical daily share price chart and data for HeartSciences since 2022 adjusted for splits and dividends. The latest closing stock price for HeartSciences as of May 28, 2025 is 3.64.
- The all-time high HeartSciences stock closing price was 340.00 on February 03, 2023.
- The HeartSciences 52-week high stock price is 6.81, which is 87.1% above the current share price.
- The HeartSciences 52-week low stock price is 2.36, which is 35.2% below the current share price.
- The average HeartSciences stock price for the last 52 weeks is 3.62.
| HeartSciences Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 3.3589 | 3.7400 | 4.4900 | 2.7084 | 3.6432 | -4.63% |
| 2024 | 6.9485 | 16.7200 | 17.9100 | 2.4800 | 3.8200 | -77.66% |
| 2023 | 83.5080 | 83.3976 | 340.0000 | 14.9300 | 17.1000 | -79.64% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.005B | $0.000B |
| Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.731B | 53.50 |
| Hims & Hers Health (HIMS) | United States | $11.944B | 124.09 |
| Tempus AI (TEM) | United States | $11.403B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.673B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.222B | 65.97 |
| Privia Health (PRVA) | United States | $2.843B | 194.33 |
| Enovis (ENOV) | United States | $1.910B | 10.65 |
| Clover Health Investments (CLOV) | United States | $1.634B | 0.00 |
| Schrodinger (SDGR) | United States | $1.578B | 0.00 |
| Phreesia (PHR) | United States | $1.484B | 0.00 |
| Omnicell (OMCL) | United States | $1.387B | 24.47 |
| Azenta (AZTA) | United States | $1.269B | 58.98 |
| 10x Genomics (TXG) | United States | $1.058B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.626B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.615B | 0.00 |
| Talkspace (TALK) | United States | $0.494B | 147.50 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.391B | 0.00 |
| TruBridge (TBRG) | United States | $0.361B | 801.00 |
| Outset Medical (OM) | United States | $0.333B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.263B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.134B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 3.32 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |